Joel Michael Maryles - 18 Mar 2022 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role: Director
Signature: /s/ Matthew Rudolph, Esq., Attorney-in-Fact for Joel Michael Maryles
Issuer symbol: CMMB
Transactions as of: 18 Mar 2022
Net transactions value: +$4,340
Form type: 4
Filing time: 21 Mar 2022, 06:04:46 UTC
Previous filing: 09 Mar 2022
Next filing: 25 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMMB	American Depositary Shares	Purchase	$2,160	+500		$4.32	500	18 Mar 2022	Direct	F1
transaction	CMMB	American Depositary Shares	Purchase	$2,180	+500	+100%	$4.36	1,000	18 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMMB	Option to Purchase American Depositary Shares	Award	$0	+6,820		$0.000000	6,820	07 Mar 2022	American Depositary Shares	6,820	$3.53	Direct	F1, F2, F3
transaction	CMMB	Option to Purchase American Depositary Shares	Award	$0	+11,884		$0.000000	11,884	19 Apr 2021	American Depositary Shares	11,884	$27.26	Direct	F1, F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2	No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3	These options vest and become exercisable in their entirety on March 16, 2023.
F4	These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.